Product Information
PENCICLOVIR 1% CREAM is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $52.1538 per GM under NDC 00093318620. Its NADAC has been published 189 times since Feb 22, 2023.
FDA first approved this application on Nov 9, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/g
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093318620
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
PENCICLOVIRApproval Type
Generic (ANDA)
FDA Application
ANDA212710FDA Approved
11/9/2022
TE Code
AB
On Market Since
11/14/2022
Pharmacological Classes
Price Statistics
The NADAC for PENCICLOVIR 1% CREAM has been published 189 times since Feb 22, 2023, and over the history we have for it it has declined 51.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $52.1538 per GM |
|---|---|
| All-time high | $108.5362 (Feb 12, 2025) |
| All-time low | $46.3296 (Aug 20, 2025) |
| 52-week high | $65.5085 |
| 52-week low | $48.8840 |
| Median price | $89.6904 |
| Average price | $82.6353 |
| Largest weekly change | -20.8% (Apr 23, 2025) |
| Weeks tracked | 189 |
| Tracking since | Feb 22, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Penciclovir market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Penciclovir market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PENCICLOVIR 1% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for PENCICLOVIR 1% CREAM, manufactured by Teva Pharmaceuticals USA Inc., is $52.1538 per GM (NDC 00093318620), effective Sep 30, 2026.
How has the price of PENCICLOVIR 1% CREAM changed over time?
Over the history we have for it, the NADAC for PENCICLOVIR 1% CREAM has declined 51.5%. It has been tracked across 189 weekly CMS publications since Feb 22, 2023.
What are the highest and lowest recorded NADAC prices for PENCICLOVIR 1% CREAM?
Since Feb 22, 2023, the NADAC for PENCICLOVIR 1% CREAM has ranged from a low of $46.3296 (Aug 20, 2025) to a high of $108.5362 (Feb 12, 2025), with a median of $89.6904 per GM.
Are there cheaper alternatives to PENCICLOVIR 1% CREAM?
No other NADAC-published product currently shares the active ingredient and strength of PENCICLOVIR 1% CREAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PENCICLOVIR 1% CREAM?
PENCICLOVIR 1% CREAM (NDC 00093318620) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.